The site every product, market and investor relationship sits behind.
A pharmaceutical corporate website is the company-level site: who you are, what you do, your pipeline or portfolio, and the entry point for investors, candidates, media and regulators, distinct from any single product’s own site.
A corporate site has to serve more audiences than almost any other page type: investors checking credibility, journalists looking for a press contact, candidates evaluating a workplace, and regulators or partners verifying basic facts. Getting the architecture right for all of them at once is the core design problem.
Information architecture built for a multi-audience visitor, a component-based CMS your team can publish from, integration with investor, careers and press systems where needed, and multilingual structure for a multi-market company.
Product-specific content that needs its own regulatory pathway gets its own home — we route it to a dedicated product website from the start, keeping the corporate site focused on what it is actually meant to serve.
The scale our pharmaceutical corporate website builds have operated at.
The priority audience differs by company. A pharmaceutical corporate website starts from that priority.
What comes up when scoping a corporate site.
Product content belongs on a dedicated product site whenever it needs its own regulatory pathway, market-specific approval status or promotional claims that don’t fit a corporate register. See product website for that build. The corporate site is the right home for company-level information — who you are, what you make, investor and career content — not brand-specific promotional claims requiring separate review.
Yes, investor relations content can live as a structured section of the corporate site rather than a separate property. This works well when disclosure volume is modest — quarterly updates, a handful of filings, basic financial summaries. See investor relations website for when the volume of disclosures grows enough to warrant its own dedicated structure and publishing workflow instead.
Most multi-market pharmaceutical companies need multilingual support on the corporate site, since affiliates and stakeholders in each market expect content in their own language. See multilingual websites for how we structure translations so language versions stay in sync as content changes, rather than drifting apart into inconsistent regional copies that someone has to reconcile manually later.
Yes, day-to-day editing is designed to happen without developer involvement. We build the corporate site on a component-based CMS, so your team can update text, images and page layouts through defined content blocks rather than raw code. See CMS implementation for how that editing experience is structured and what still legitimately requires developer support afterward.
A corporate website often sits alongside these other builds.
A new corporate presence, or one that no longer reflects the company. Tell us your audiences and we will tell you how we would approach the pharmaceutical corporate website.